Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-κB
暂无分享,去创建一个
Csaba Szabó | C. Szabó | T. Kern | L. Zheng | Timothy S. Kern | L. Zheng | Ling-Yun Zheng
[1] Bernd Kirchhof,et al. Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] M. Lorenzi,et al. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.
[3] A. Adamis,et al. Is diabetic retinopathy an inflammatory disease? , 2002, The British journal of ophthalmology.
[4] M. Hottiger,et al. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders , 2002, Cellular and Molecular Life Sciences CMLS.
[5] M. Davis,et al. Patterns of ischemia in diabetic retinopathy. , 1976, Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology.
[6] Mark P. Mattson,et al. NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .
[7] C. Gerhardinger,et al. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. , 2002, Diabetes.
[8] M. O’connor,et al. Poly(ADP-Ribose) Polymerase-1 Regulates Activation of Activator Protein-1 in Murine Fibroblasts1 , 2003, The Journal of Immunology.
[9] W. Chang,et al. The Sequence-specific DNA Binding of NF-κB Is Reversibly Regulated by the Automodification Reaction of Poly (ADP-ribose) Polymerase 1* , 2001, The Journal of Biological Chemistry.
[10] F. Gallyas,et al. Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents* , 2002, Critical care medicine.
[11] Changlian Zhu,et al. Involvement of apoptosis‐inducing factor in neuronal death after hypoxia‐ischemia in the neonatal rat brain , 2003, Journal of neurochemistry.
[12] M. Gillies,et al. The retina: oxidative stress and diabetes , 2003, Redox report : communications in free radical research.
[13] T. Kern,et al. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. , 2001, Diabetes.
[14] F. Ismail-Beigi,et al. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. , 2000, Diabetes.
[15] T. Okamoto,et al. Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. , 2000, The Biochemical journal.
[16] S. Snyder,et al. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] K. Murthy,et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.
[18] S. Chakrabarti,et al. Diabetes-induced Activation of Nuclear Transcriptional Factor in the Retina, and its Inhibition by Antioxidants , 2003, Free radical research.
[19] Z. Yang,et al. Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. , 2000, Shock.
[20] Ulrich Schraermeyer,et al. A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] T. Gilmore,et al. Control of apoptosis by Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[22] A. Baldwin. Series Introduction: The transcription factor NF-κB and human disease , 2001 .
[23] B Kirchhof,et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.
[24] É. Szabó,et al. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. , 2002, Diabetes.
[25] B. Aronow,et al. Absence of Poly(ADP-ribose) Polymerase-1 Alters Nuclear Factor-κB Activation and Gene Expression of Apoptosis Regulators after Reperfusion Injury , 2003, Molecular medicine.
[26] R. Alvarez-González,et al. Regulation of p53 Sequence-specific DNA-binding by Covalent Poly(ADP-ribosyl)ation* , 2001, The Journal of Biological Chemistry.
[27] C. Szabó,et al. DNA damage induced by peroxynitrite: subsequent biological effects. , 1997, Nitric oxide : biology and chemistry.
[28] S. Mohr,et al. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.
[29] M. Mattson,et al. NF-kappaB in neuronal plasticity and neurodegenerative disorders. , 2001, The Journal of clinical investigation.
[30] C. Szabó,et al. Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. , 1998, Journal of immunology.
[31] C. Szabó,et al. The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.
[32] Timothy S Kern,et al. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.
[33] N. Perkins. The Rel/NF-κB family: friend and foe , 2000 .
[34] V. Dawson,et al. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.
[35] K. Miyarnoto. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .
[36] Mark A. Smith,et al. Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine , 2002, Journal of neurochemistry.
[37] J. Węsierska‐Gądek,et al. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. , 2001, Cellular & molecular biology letters.
[38] Fei Li,et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. , 2004, Diabetes.
[39] C. Hirschberg. Golgi nucleotide sugar transport and leukocyte adhesion deficiency II , 2001 .
[40] S. Snyder,et al. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia , 1999, Brain Research.
[41] T. Kern,et al. Retinal glutamate in diabetes and effect of antioxidants , 2001, Neurochemistry International.
[42] M. Covic,et al. The Enzymatic and DNA Binding Activity of PARP-1 Are Not Required for NF-κB Coactivator Function* , 2001, The Journal of Biological Chemistry.
[43] T. Dawson,et al. Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.
[44] M. Kameoka,et al. Expression of histone acetyltransferases was down-regulated in poly(ADP-ribose) polymerase-1-deficient murine cells. , 2003, Biochemical and biophysical research communications.
[45] N. Perkins. The Rel/NF-kappa B family: friend and foe. , 2000, Trends in biochemical sciences.
[46] A. Baldwin. Series introduction: the transcription factor NF-kappaB and human disease. , 2001, The Journal of clinical investigation.
[47] L. Rossetti,et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.
[48] M. Moskowitz,et al. Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disorders , 2003, Journal of neurochemistry.
[49] A. Spradling,et al. Chromatin Loosening by Poly(ADP)-Ribose Polymerase (PARP) at Drosophila Puff Loci , 2003, Science.
[50] M. Hottiger,et al. Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1* , 2003, Journal of Biological Chemistry.
[51] Y. Ogura,et al. Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. , 2003, The American journal of pathology.
[52] R. Andriantsitohaina,et al. Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice , 1999, The EMBO journal.
[53] G. Romeo,et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. , 2000, Investigative ophthalmology & visual science.
[54] C. Le Page,et al. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. , 1998, Biochemical and biophysical research communications.